Utah Medical Products price to book ratio UTMD
Market value divided by the book value of the company's net assets, since 2020.
- Today, Oct 23, 2026
- 1.9×
- 6-year median
- 2.6×
- Against its 6-year history
- 40th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 1.5× to 4.0×
- Peer median
- 2.6×
Utah Medical Products' price to book ratio is 1.9× as of Oct 23, 2026.
That is below its 6-year median of 2.6×, close to the middle of its last 6 years.
Over that time it ranged from 1.5× in Apr 2025 to 4.0× in Nov 2021.
The median for 10 medical instruments and supplies stocks of a similar size is 2.6×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.9× | 1.5× | 2.0× |
| 2025 | 1.5× | 1.5× | 1.7× |
| 2024 | 1.7× | 1.7× | 2.5× |
| 2023 | 2.5× | 2.3× | 3.3× |
| 2022 | 3.4× | 2.7× | 3.4× |
| 2021 | 3.3× | 2.9× | 4.0× |
| 2020 | 3.1× | 3.0× | 3.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Utah Medical Products' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| UTMDUtah Medical Products | 1.9× |
| INFUInfuSystem | 4.7× |
| PDEXPro DEX | 4.2× |
| EMBCEmbecta | n/m |
| TCMDTactile Systems Technology | 2.4× |
| MDXGMimedx | 2.6× |
| KEQUKewaunee Scientific | 1.3× |
| MOVMovado | 1.4× |
| APTAlpha Pro Tech | 0.9× |
| IRMDIradimed | 10.8× |
| STAAStaar Surgical | 3.1× |
| Peer median | 2.6× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Utah Medical Products
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.